Related references
Note: Only part of the references are listed.Association Between Serum Myostatin Levels, Hospital Mortality, and Muscle Mass and Strength Following ST-Elevation Myocardial Infarction
Paula G. S. Oliveira et al.
HEART LUNG AND CIRCULATION (2022)
Association of serum adiponectin and myostatin levels with skeletal muscle in patients with obesity: A cross-sectional study
Satoshi Kurose et al.
PLOS ONE (2021)
Predicting 90-Day Outcome After Thrombectomy: Baseline-Adjusted 24-Hour NIHSS Is More Powerful Than NIHSS Score Change
Eva A. Mistry et al.
STROKE (2021)
Growth Differentiation Factor-8 (GDF8)/Myostatin Is a Predictor of Troponin I Peak and a Marker of Clinical Severity after Acute Myocardial Infarction
Alexandre Meloux et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The neuroprotective and neurorestorative effects of growth differentiation factor 11 in cerebral ischemic injury
Yan Zhao et al.
BRAIN RESEARCH (2020)
Stroke History is an Independent Risk Factor for Poor Prognosis in Ischemic Stroke Patients: Results from a Large Nationwide Stroke Registry
Haiqiang Qin et al.
CURRENT NEUROVASCULAR RESEARCH (2020)
Myostatin Is Associated With Cognitive Decline in an Animal Model of Alzheimer's Disease
Yung-Shuen Lin et al.
MOLECULAR NEUROBIOLOGY (2019)
Sarcopenia: revised European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft et al.
AGE AND AGEING (2019)
Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Catherine Owens Johnson et al.
LANCET NEUROLOGY (2019)
Predictive value of serum myostatin for the severity and clinical outcome of heart failure
Pingan Chen et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
Neuroprotective Potential of GDF11: Myth or Reality?
Luc Rochette et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Impact of the Ageing Population on the Burden of Stroke: The Dijon Stroke Registry
Yannick Bejot et al.
NEUROEPIDEMIOLOGY (2019)
Growth differentiation factor 11 improves neurobehavioral recovery and stimulates angiogenesis in rats subjected to cerebral ischemia/reperfusion
Jingxi Ma et al.
BRAIN RESEARCH BULLETIN (2018)
Growth Differentiation Factor 11 Promotes Neurovascular Recovery After Stroke in Mice
Lu Lu et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Myostatin expression in the adult rat central nervous system
Yutaro Hayashi et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2018)
Growth Differentiation Factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice
Ceren Ozek et al.
SCIENTIFIC REPORTS (2018)
Differential effects of myostatin deficiency on motor and sensory axons
Maria R. Jones et al.
MUSCLE & NERVE (2017)
Modulation of GDF11 expression and synaptic plasticity by age and training
Emanuela De Domenico et al.
ONCOTARGET (2017)
Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke
Marine Maud Desgeorges et al.
SCIENTIFIC REPORTS (2017)
Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease
Marissa J. Schafer et al.
CELL METABOLISM (2016)
Biochemistry and Biology of GDF11 and Myostatin Similarities, Differences, and Questions for Future Investigation
Ryan G. Walker et al.
CIRCULATION RESEARCH (2016)
Epidemiology of stroke in Europe and trends for the 21st century
Yannick Bejot et al.
PRESSE MEDICALE (2016)
Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts
Kristoff A. Olson et al.
EUROPEAN HEART JOURNAL (2015)
Molecular Mechanisms of Skeletal Muscle Atrophy in a Mouse Model of Cerebral Ischemia
Marine Maud Desgeorges et al.
STROKE (2015)
Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay
H. Robert Bergen et al.
SKELETAL MUSCLE (2015)
Endocranial and masticatory muscle volumes in myostatin-deficient mice
Nathan Jeffery et al.
ROYAL SOCIETY OPEN SCIENCE (2014)
Expression of Myostatin in Neural Cells of the Olfactory System
Shunsuke Iwasaki et al.
MOLECULAR NEUROBIOLOGY (2013)
Endocrine and Clinical Correlates of Myostatin Serum Concentration in Men-the STRAMBO Study
Pawel Szulc et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy
Hansjoerg Rindt et al.
NEUROMUSCULAR DISORDERS (2012)
Axon and muscle spindle hyperplasia in the myostatin null mouse
Mohamed I. Elashry et al.
JOURNAL OF ANATOMY (2011)
Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy
Ferrill F. Rose et al.
HUMAN MOLECULAR GENETICS (2009)
Diabetes worsens the outcome of acute ischemic stroke
MM Kaarisalo et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Share Paper
